Autologous stem cell transplantation for relapsed/refractory large B-cell lymphoma: a multicenter GETH-TC/GELTAMO study

Abstract: We performed a retrospective multicenter study including 791 patients with relapsed/refractory (R/R) large B-cell lymphoma (LBCL) who underwent autologous stem cell transplantation (ASCT). After a median follow-up of 74 months from infusion, 65% were alive and 84% free of disease. Progress...

Full description

Bibliographic Details

Published in:	Blood Advances
Main Authors:	Leyre Bento, Antonio Gutiérrez, Carmen Martínez, María Consejo Ortí Verdet, Marina Sorribes, Ana Carolina Caballero, Marta Peña, Ariadna Pérez, Ana Jiménez-Ubieto, Lucía Medina, Mariana Bastos-Oreiro, Paula Fernández Caldas-González, Belén Navarro, Isabel Salcedo, Pau Abrisqueta, Ignacio Español, Javier Cornago, Fernando Martín-Moro, Lucía García, Pilar Gómez, María Rosario Varela, María Puente, Joud Zanabili, Teresa Zudaire, Izaskun Zeberio, Raquel del Campo, Leslie González, Pedro González, Cristina Blázquez, Jordina Rovira, Marta Sitges, Mireia Franch-Sarto, Almudena Cabero, Alberto Mussetti, Juan Montoro, Antonia Sampol, Anna Sureda, Dolores Caballero, Alejandro Martín García-Sancho
Format:	Article
Language:	English
Published:	Elsevier 2025-07-01
Online Access:	http://www.sciencedirect.com/science/article/pii/S2473952925001946